BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US Corporate Board Director Changes SEC Filings β€” January 14, 2026

USA Board Room Changes

31 high priority31 total filings analysed

Executive Summary

A remarkable surge of 31 Form 8-K filings disclosing officer changes under Item 5.02 occurred on a single day, January 15, 2026, across diverse US-listed companies spanning biotech, financials, tech, apparel, and more, representing an unprecedented temporal clustering in boardroom activity. All filings exhibit neutral sentiment with low-to-medium materiality (2-5/10) and pervasive lack of specifics on positions, individuals, appointment/resignation status, or reasons, obscuring potential drivers like planned successions or distress signals. This opacity amid high volume signals potential systemic leadership churn or external catalysts (e.g., regulatory deadlines), warranting vigilance for follow-on disclosures that could reveal sector-wide trends or governance risks with portfolio implications.

Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from January 13, 2026.

Investment Signals(3)

  • β–²

    Unusual single-day volume of 31 neutral officer changes suggests coordinated board refreshes rather than crises [BULLISH] - Broad market

  • β–²

    Pervasive disclosure gaps may mask underlying issues, increasing short-term volatility risk [BEARISH] - All companies

  • β–²

    No disclosed negative reasons (e.g., for cause terminations) across filings [BULLISH] - Biotech cluster (Aspire, Hepion, Cocrystal, Alpha Cognition)

Risk Flags(3)

  • β–Ό

    Extreme temporal concentration (all 31 on Jan 15) hints at possible data anomaly, external shock, or delayed reporting pile-up, amplifying uncertainty

  • β–Ό

    Universal lack of details on key officers (e.g., CEO/CFO), reasons, and succession plans raises governance transparency red flags across sectors

  • β–Ό

    One filing links officer change to financial obligation acceleration (Item 2.04), signaling potential covenant breaches or distress [AccNo: 0001637880-26-000003]

Opportunities(3)

  • β—†

    Proactive parsing of full 8-K exhibits (Item 9.01) for hidden details on high-materiality names like Pinnacle Financial and XOMA Royalty to uncover alpha in leadership upgrades

  • Biotech/pharma cluster (7+ filings
    β—†

    Aspire, Hepion, Cocrystal, etc.) may indicate sector-wide talent influx; position for M&A or pipeline acceleration post-refresh

  • β—†

    Financials cluster (Lakeland, Pinnacle, Citizens, SEI, CNO) offers pair-trade potential: overweight stable peers amid transition uncertainty

Sector Themes(3)

  • β—†

    Biotech/pharma shows highest concentration (Aspire Biopharma, Hepion, Cocrystal, Alpha Cognition, etc.), potentially signaling talent mobility or funding-driven board overhauls amid 2026 innovation push

  • β—†

    Regional banks/financial services (Lakeland, Pinnacle, Citizens, SEI) exhibit clustered changes, possibly tied to regulatory scrutiny or rate environment shifts

  • β—†

    Tech/software and consumer (Atlassian, AppFolio, Toast, Under Armour, Ralph Lauren) reflect broad leadership tweaks, hinting at strategic pivots in competitive landscapes

Watch List(4)

  • 0001637880-26-000003] - Item 2.04 financial trigger + officer change combo flags acute liquidity/governance risk

  • πŸ‘

    Pinnacle Financial Partners & Lakeland Financial - Highest materiality (5/10) in financials cluster; monitor for CEO/CFO details signaling stability

  • πŸ‘

    Biotech cluster (Hepion, Cocrystal, SmartKem, Alpha Cognition) - Volume suggests sector catalyst; track Form 4s for insider buying/selling

  • πŸ‘

    Under Armour & Ralph Lauren - Apparel peers amid consumer shifts; watch for execution risk from undisclosed transitions

Filing Analyses(31)
Aspire Biopharma Holdings, Inc.8-Kneutralmateriality 3/10

15-01-2026

Aspire Biopharma Holdings, Inc. disclosed an officer change via Form 8-K filed on January 15, 2026 (AccNo: 0001493152-26-002326, Size: 600 KB). The filing references Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, nature of change, reasons, or compensation are provided.

Lumexa Imaging Holdings, Inc.8-Kneutralmateriality 3/10

15-01-2026

Lumexa Imaging Holdings, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001193125-26-013511, size: 237 KB) disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer involved, position affected, appointment or resignation status, reasons, or compensation were disclosed.

CUMULUS MEDIA INC8-Kneutralmateriality 3/10

15-01-2026

Cumulus Media Inc filed a Form 8-K on January 15, 2026 (AccNo: 0001058623-26-000004, Size: 183 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also includes Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected officer, reason for change, or compensation are disclosed.

GBT Technologies Inc.8-Kneutralmateriality 2/10

15-01-2026

GBT Technologies Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001731122-26-000064), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) with exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or compensation provided in the available information. Sector not specified.

GENUINE PARTS CO8-Kneutralmateriality 3/10

15-01-2026

Genuine Parts Co (GENUINE PARTS CO) disclosed an Officer Change event via Form 8-K filed on January 15, 2026 (AccNo: 0001193125-26-013595, Size: 159 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or quantitative data provided.

Unknown8-Kneutralmateriality 2/10

15-01-2026

The company filed an 8-K on January 15, 2026 (AccNo: 0001104659-26-003905, Size: 20 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Event Type: Officer Change, Date: January 15, 2026, Source: us_sec. No specific details on the officer's name, position, appointment/resignation status, reasons, or quantitative data provided.

Under Armour, Inc.8-Kneutralmateriality 3/10

15-01-2026

Under Armour, Inc. filed an 8-K on January 15, 2026 (AccNo: 0001336917-26-000017, Size: 195 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), appointment/resignation status, reasons, or timing are disclosed in the provided filing summary. Sector is not specified.

Unknown8-Kneutralmateriality 5/10

15-01-2026

The company filed a Form 8-K on January 15, 2026 (AccNo: 0001637880-26-000003, Size: 133 KB), disclosing an officer change under Item 5.02 and a triggering event that accelerates or increases a direct financial obligation or off-balance sheet arrangement under Item 2.04. The event occurred on January 15, 2026, with event type specified as Officer Change. No specific details on the officer position, appointment/resignation, reasons, financial impacts, or quantitative data are disclosed.

LAKELAND FINANCIAL CORP8-Kneutralmateriality 3/10

15-01-2026

Lakeland Financial Corp filed an 8-K on January 15, 2026 (AccNo: 0000721994-26-000007, Size: 5 MB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on the affected officer, position, reason for change, or compensation are disclosed in the provided filing summary.

RALPH LAUREN CORP8-Kneutralmateriality 3/10

15-01-2026

Ralph Lauren Corp filed a Form 8-K on January 15, 2026 (AccNo: 0000950142-26-000179, Size: 198 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation, reasons, or compensation provided in the summary. Sector not specified.

Atlassian Corp8-Kneutralmateriality 3/10

15-01-2026

Atlassian Corp filed a Form 8-K on January 15, 2026 (AccNo: 0001650372-26-000003, Size: 147 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position, individual name, appointment or resignation, reason, or timing are provided in the filing summary. Sector is not specified.

Pinnacle Financial Partners, Inc.8-Kneutralmateriality 5/10

15-01-2026

Pinnacle Financial Partners, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0002082866-26-000004, Size: 1 MB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are disclosed in the provided filing summary. Sector not specified.

NELNET INC8-Kneutralmateriality 3/10

15-01-2026

NELNET INC filed a Form 8-K on January 15, 2026 (AccNo: 0001258602-26-000002, Size: 230 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensatory arrangements are provided in the filing summary. Sector is not specified.

WOLFSPEED, INC.8-Kneutralmateriality 3/10

15-01-2026

Wolfspeed, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0000895419-26-000006, Size: 240 KB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, appointment/resignation status, reasons, or quantitative data are provided in the filing summary.

APPFOLIO INC8-Kneutralmateriality 3/10

15-01-2026

AppFolio Inc filed a Form 8-K on January 15, 2026 (AccNo: 0001433195-26-000003, Size: 137 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected officer, position, appointment or resignation status, reasons, or any quantitative data are provided in the summary. Event type is Officer Change; sector not specified.

Hepion Pharmaceuticals, Inc.8-Kneutralmateriality 3/10

15-01-2026

Hepion Pharmaceuticals, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001493152-26-002428, Size: 206 KB), disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on positions, individuals, reasons, or financial terms are disclosed.

Cocrystal Pharma, Inc.8-Kneutralmateriality 3/10

15-01-2026

Cocrystal Pharma, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001493152-26-002422, Size: 214 KB) disclosing an officer change under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason, or compensation provided in the available information. Sector not specified.

CITIZENS FINANCIAL SERVICES INC8-Kneutralmateriality 3/10

15-01-2026

CITIZENS FINANCIAL SERVICES INC filed a Form 8-K on January 15, 2026 (AccNo: 0000739421-26-000005, Size: 147 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer position, individuals involved, reasons for change, or quantitative data are provided in the summary.

Rainmaker Worldwide Inc.8-Kneutralmateriality 2/10

15-01-2026

Rainmaker Worldwide Inc. disclosed an officer change via Form 8-K filed on January 15, 2026 (AccNo: 0001493152-26-002433, Size: 256 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided. Sector is not specified.

SEI INVESTMENTS CO8-Kneutralmateriality 3/10

15-01-2026

SEI Investments Co filed a Form 8-K on January 15, 2026 (AccNo: 0000929638-26-000165, Size: 303 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 includes Financial Statements and Exhibits. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative impacts are provided.

XOMA Royalty Corp8-Kneutralmateriality 4/10

15-01-2026

XOMA Royalty Corp filed a Form 8-K on January 15, 2026 (AccNo: 0001193125-26-014142, Size: 231 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Event type is Officer Change from US market, source us_sec, sector not specified. No specific details on affected position, appointment/resignation, reasons, names, or quantitative data provided.

BEL FUSE INC /NJ8-Kneutralmateriality 3/10

15-01-2026

BEL FUSE INC /NJ filed a Form 8-K on January 15, 2026 (AccNo: 0001437749-26-001362, Size: 438 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or quantitative data are provided. Sector not specified.

CRAWFORD & CO8-Kneutralmateriality 3/10

15-01-2026

Crawford & Co filed a Form 8-K on January 15, 2026 (AccNo: 0001104659-26-004113, Size: 366 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on affected positions, individuals, reasons for change, or quantitative data provided. Sector not specified.

SmartKem, Inc.8-Kneutralmateriality 3/10

15-01-2026

SmartKem, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001104659-26-004112) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or any quantitative data such as compensation amounts or share counts are provided in the available information. Sector is not specified.

FiEE, Inc.8-Kneutralmateriality 2/10

15-01-2026

FiEE, Inc. filed an 8-K on January 15, 2026 (AccNo: 0001829126-26-000331, Size: 193 KB) disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer(s) involved, position, reason for change, or any quantitative data are provided in the available information. Sector not specified.

Toast, Inc.8-Kneutralmateriality 3/10

15-01-2026

Toast, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001650164-26-000024), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.

SunCoke Energy, Inc.8-Kneutralmateriality 3/10

15-01-2026

SunCoke Energy, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001514705-26-000002, Size: 227 KB) disclosing an officer change under Item 5.02, covering departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on the officer involved, position affected, reason for change, or quantitative data are provided.

Venu Holding Corp8-Kneutralmateriality 3/10

15-01-2026

Venu Holding Corp filed a Form 8-K on January 15, 2026 (AccNo: 0001493152-26-002440, Size: 233 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided.

CNO Financial Group, Inc.8-Kneutralmateriality 3/10

15-01-2026

CNO Financial Group, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001224608-26-000005, Size: 542 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, reasons, or compensation are provided in the summary. Sector is not specified.

XCF Global, Inc.8-Kneutralmateriality 3/10

15-01-2026

XCF Global, Inc. filed an 8-K on January 15, 2026 (AccNo: 0001493152-26-002456, Size: 293 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative data are disclosed in the provided filing summary. Sector is not specified.

Alpha Cognition Inc.8-Kneutralmateriality 3/10

15-01-2026

Alpha Cognition Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001213900-26-004765, size: 193 KB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary.

Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 31 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US Corporate Board Director Changes SEC Filings β€” January 14, 2026 | Gunpowder Blog